Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.For licensed clinicians. Educational demonstration on synthetic data. Never enter real patient identifiers or protected health information: everything runs in your browser and nothing is sent or stored. Clinical decision support only; not FDA cleared; physician review is required.
CPE-007 · Scope and validity
CV-SCOPE-02: Age bands that change the approach
Age bands that change the approach. Evaluates age 20 to 39 (10-year risk is not estimated).
Active rulePriority 3Cardio engine v1.0.0
Condition
- age 20 to 39 (10-year risk is not estimated)
- OR age 80 and over (limited trial evidence)
What it reports
- Age 20–39: lifetime risk, family history and severe hypercholesterolemia matter more than a 10-year estimate
- Age 80 and over: decisions are individualized
Diagnostic boundary
- Does not set a category.
Evidence
- EV-ACCAHA-CHOL-2018Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation. 2019;139(25):e1082-e1143.Supports: Risk categories, risk enhancers, statin benefit groups and the coronary-calcium decision aid Very-high-risk ASCVD definition
- EV-ACCAHA-PREV-2019Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease. Circulation. 2019;140(11):e596-e646.Supports: Primary prevention approach, risk estimation and modifiable risk factors
Cases where this rule fires
Open a case to see this rule fire with real inputs, then change the values until it stops.
Try Biod in your practice
The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.